Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bronchodilator effect and safety of multiple daily
doses of arformoterol administered for 12 weeks as maintenance treatment in patients with
COPD